History of Postmarketing Surveillance in the United States

Venning GR : Identification of adverse reactions to drugs. II. How were 18 important adverse reactions discovered and with what delay? 1983; Brit Med J 286:289.

Doll R. : Unwanted effects of drugs. 1971; Brit Med Bull 27:25.

Sadusk JF Jr. : The monitoring of adverse reactions to drugs. 1968; Drug Inform Bull 2:66.

DeHaan RM : Clinical studies to evaluate safety and efficacy in phase IV investigations. 1968; Drug Inform Bull 2:84.

Witts LJ : Adverse reactions to drugs. 1965; Brit Med J 2:1081.

Jick H. Walker AM Spriet-Pourra C. : Postmarketing follow-up. 1979; JAMA 242:2310.

Postmarketing Surveillance of Prescription Drugs, Office of Technology Assessment, Congress of the United States, November 1982.

Inman WHW : Thalidomide, practolol—what next, in Colombo F. Shapero W. Sloane D. Tognoni G. (eds): Epidemiological Evaluation of Drugs. Littleton, PSG Publishing Co, Inc, 1977, pp 231–240.